EUVIMEDEUVIMED entdecken
Crossref

Rewiring Lysine Catabolism in Cancer Leads to Increased Histone Crotonylation and Immune Escape

Kosta Besermenji, Rita Petracca iD

ChemBioChem · 2024

DOI: 10.1002/cbic.202400638 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemBioChem, 2024. Verfasst von Kosta Besermenji und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, David De Wied building, Universiteitsweg 99, 3584 CG, Utrecht, NL. Hauptthemen laut MEDLINE: Acyl Coenzyme A, Histones, Lysine. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Crotonyl‐CoA (cr‐CoA) is a metabolite derived directly from the catabolism of lysine (Lys) and tryptophan (Trp) or from the β‐oxidation of fatty acids. In glioblastoma stem cells (GSCs), histone H4 crotonylation levels are significantly elevated, which appears to positively correlate with tumor growth. This increase in crotonyl‐CoA production is attributed to the overexpression of specific Lys transporters on the cell membrane, leading to higher free lysine levels. Additionally, the overexpression of glutaryl‐CoA dehydrogenase (GCDH), the enzyme responsible for crotonyl‐CoA production, further contributes to this increase. When GCDH is depleted or under a lysine‐restricted diet, genes involved in type I interferon (IFN) signaling are upregulated, resulting in tumor growth suppression. Type I interferons are a group of cytokines critical for antiviral responses and immunoregulation. This highlights how cancer cells exploit crotonylation to modulate the immune response. This work opens up new avenues for investigating how cancer cells rewire their metabolism to increase crotonylation and evade the immune system.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acyl Coenzyme AHistonesLysineAnimalsHumansMiceCell Line, TumorInterferon Type INeoplasmsTumor Escape

Stichwörter der Autor:innen

Crotonylationcancerimmune escapemetabolic reprogramming

Substanzen

Acyl Coenzyme Acrotonyl-coenzyme AHistonesInterferon Type ILysine

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, David De Wied building, Universiteitsweg 99, 3584 CG, Utrecht, NL.

ORCID-Profile: Rita Petracca

Zitieren

APA

Besermenji, K., & Petracca, R. (2024). Rewiring Lysine Catabolism in Cancer Leads to Increased Histone Crotonylation and Immune Escape. ChemBioChem. https://doi.org/10.1002/cbic.202400638

Vancouver

Besermenji K, Petracca R. Rewiring Lysine Catabolism in Cancer Leads to Increased Histone Crotonylation and Immune Escape. ChemBioChem. 2024. doi:10.1002/cbic.202400638

BibTeX
@article{Besermenji2024,
  author = {Besermenji, Kosta and Petracca, Rita},
  title = {Rewiring Lysine Catabolism in Cancer Leads to Increased Histone Crotonylation and Immune Escape},
  journal = {ChemBioChem},
  year = {2024},
  doi = {10.1002/cbic.202400638}
}
Kostenlos starten →